Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1996
10/15/1996US5565484 Cardiovascular disorders
10/15/1996US5565483 3-substituted oxindole derivatives as potassium channel modulators
10/15/1996US5565480 Substituted histidines
10/15/1996US5565479 Imidazolyl fused thiazoles antiserotonine agent
10/15/1996US5565478 Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
10/15/1996US5565477 Therapeutic amides
10/15/1996US5565476 Renin inhibitors for treatment of congestive heart failure and hypertension
10/15/1996US5565475 Method of treating urinary bladder dysfunctions with 3-tetrahydropyridine derivatives
10/15/1996US5565474 1-heteroarylazetidines and -pyrrolidines process for their preparation and pharmaceutical compositions containing them
10/15/1996US5565471 Method for inhibiting thrombosis
10/15/1996US5565470 Cycloaminoalkoxyphenyl derivatives, a process for their preparation as well as the compositions containing them
10/15/1996US5565469 Benzimidazoles and pharmaceutical compositions containing them
10/15/1996US5565468 4,5,6,7-tetrahydropyrazolo(1,5-a)pyrid-3-yl, pyrazolo(1,5-a)pyrid-3-yl, imidazo(1,5-a)pyridin-1-yl or imidazo(1,2-a)-pyrid-3-yl oxime derivatives
10/15/1996US5565467 Androstenone derivative
10/15/1996US5565466 Methods for modulating the human sexual response
10/15/1996US5565465 Treatment of urinary incontinence
10/15/1996US5565464 Compounds having angiotensine II antagonistic activity
10/15/1996US5565463 9-subtituted-8-unsubstituted-9-deazaguanines
10/15/1996US5565462 Pentoxifylline, propentofylline and(or) torbafylline
10/15/1996US5565460 Therapeutic purine agents for parkinson's disease
10/15/1996US5565457 For treatment of myocardial ischemias and cerebral vascular disorders
10/15/1996US5565455 Method for treating substance abuse disorders
10/15/1996US5565454 Method for preventing intervention-associated stenosis and other symptoms associated with stenosis of blood vessels following non-bypass, invasive interventions
10/15/1996US5565453 Antipsychotic agent
10/15/1996US5565452 9-amino-pyridazino[4',5':3,4]pyrrolo-[2,1-A]isoquinolines and the use thereof for the production of pharmaceutical preparations
10/15/1996US5565450 Pesticides, insecticides
10/15/1996US5565448 Antiinflammatory agent, cardiovascular disorders, septic shock
10/15/1996US5565447 Almotriptan malate; treating headaches, movement disorders, depression, anxiety
10/15/1996US5565446 Useful in treatment of inflammatory diseases
10/15/1996US5565444 Androgen derivative
10/15/1996US5565443 Contraceptics
10/15/1996US5565442 Dissolving in solvent with antioxidant and polyoxyalkyl stabilizer; compositing with carrier or excipient to impart solid characteristics; desolventizing; useful in conditions of vitamin d deficiency
10/15/1996US5565441 Phosphonoacetic esters and acids as anti-inflammatories
10/15/1996US5565440 Antiinflammatory, antipyritic, analgesic, antirheumatic, antiarthritic or antiosteoprosis agent
10/15/1996US5565439 Methods of using lysophosphatidic acid for treating hyperproliferative conditions
10/15/1996US5565438 L-nucleosides for the treatment of epstein-bar virus
10/15/1996US5565437 Aids treatment
10/15/1996US5565436 Extracts from cultures of mushroom mycelia
10/15/1996US5565435 Enzyme catalyzed reaction between quercetin and glucose
10/15/1996US5565434 Reducing intraocular pressure with topical application
10/15/1996US5565433 Administering in treatment and prevention of inflammatory diseases
10/15/1996US5565432 Smooth muscle cell proliferation inhibitors
10/15/1996US5565430 Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors
10/15/1996US5565418 Retroviral protease inhibiting compounds
10/15/1996US5565362 DNA sequences to target proteins to the mammary gland for efficient secretion
10/15/1996US5565345 Reduction by the action of a microorganism
10/15/1996US5565321 Isolating nucleic acid, amplifying nucleic acid derived from cd40 ligand gene, determining nucleotide sequence, comparing to standard, determining if protein is expressed which binds cd40
10/15/1996US5565214 Stable therapeutic oil filled soft gelatin capsules
10/15/1996US5565206 Ionic microbiocide absorbed, bonded on ion exchange resin
10/15/1996US5565191 Sunscreen agents
10/15/1996US5565188 Therapeutiac or diagnostic agents having polyoxyalkylene glycol triblock polymers adsorbed on particle surfaces
10/15/1996CA2042972C Treatment of ocular hypertension with a synergistic combination for ocular administration
10/15/1996CA2029703C Oxazolidinedione hypoglycemic agents
10/15/1996CA2020027C Isoquinoline- or quinoline-sulfonamide derivative and a pharmaceutical composition comprising the same
10/15/1996CA1338647C Inhibitors of lysyl oxidase
10/15/1996CA1338646C (arylsulphonyl) nitromethanes, processes for their preparation and their use in pharmaceutical compositions
10/15/1996CA1338645C Isolation, structural elucidation and synthesis of novel antineoplastic substances denominated "combretastatins"
10/15/1996CA1338644C Production of 3-allyl- and 3-butenyl-3-cephems
10/13/1996WO1996033727A1 NOVEL USE OF (S)-ADENOSYL-L-METHIONINE (SAMe)
10/13/1996CA2216854A1 A novel use of (s)-adenosyl-l-methionine (same)
10/11/1996CA2173693A1 4-indolylpiperazinyl derivatives
10/11/1996CA2173690A1 4-indolylpiperazinyl derivatives
10/11/1996CA2173660A1 Thiazolidinedione derivatives having antidiabetic, hypolipidaemic, and antihypertensive properties
10/10/1996WO1996031621A2 Method for determining the responsiveness of individuals to 5-ht2 receptor modulating agents
10/10/1996WO1996031617A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996WO1996031613A1 Expression library immunization
10/10/1996WO1996031533A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same
10/10/1996WO1996031532A1 Sugar-modified cytostatics
10/10/1996WO1996031527A1 Protease inhibiting succinic acid derivatives
10/10/1996WO1996031515A1 Selected soluble esters of hydroxyl-containing indolocarbazoles
10/10/1996WO1996031514A1 Ascomycins
10/10/1996WO1996031513A1 Novel intermediates and process for the manufacture of camptothecin derivatives (cpt-11) and related compounds
10/10/1996WO1996031511A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/10/1996WO1996031510A1 Pyrazole derivatives and processes for the preparation thereof
10/10/1996WO1996031509A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVES
10/10/1996WO1996031508A1 Biphenylamide derivatives as 5ht1d antagonists
10/10/1996WO1996031501A1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
10/10/1996WO1996031499A1 Novel heterocyclic compounds
10/10/1996WO1996031498A1 Novel heterocyclic compounds
10/10/1996WO1996031497A1 Novel heterocyclic compounds
10/10/1996WO1996031493A1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
10/10/1996WO1996031492A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
10/10/1996WO1996031491A1 Triazole antifungal agent
10/10/1996WO1996031490A1 Azole compounds with antimycotic activity for human and veterinary use
10/10/1996WO1996031487A1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
10/10/1996WO1996031486A1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity
10/10/1996WO1996031485A1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity
10/10/1996WO1996031481A1 Novel heterocyclic compounds
10/10/1996WO1996031478A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/10/1996WO1996031477A1 Tricyclic compounds useful for inhibition of farnesyl protein transferase
10/10/1996WO1996031475A2 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors
10/10/1996WO1996031474A1 Novel heterocyclic compounds
10/10/1996WO1996031471A1 Novel method
10/10/1996WO1996031468A1 Novel heterocyclic compounds
10/10/1996WO1996031462A1 Benzamides for neurodegenerative disorder treatment
10/10/1996WO1996031461A1 Phenoxyethylamine derivatives having high affinity for the 5-ht1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives
10/10/1996WO1996031452A1 9-substituted porphycenes
10/10/1996WO1996031451A1 9-substituted porphycenes
10/10/1996WO1996031240A1 Increasing the hdl level and the hdl/ldl ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids
10/10/1996WO1996031239A1 Pharmaceutical composition containing pectin and a phospholipid, used as an antidiarrheal and antiulcer agent
1 ... 6870 6871 6872 6873 6874 6875 6876 6877 6878 6879 6880 6881 6882 6883 6884 6885 6886 6887 6888 6889 6890 ... 7860